@article{8638216,
  abstract     = {{Background The correlation between different methods for the detection of pneumococcal polysaccharide vaccine (PPV) responses to diagnose specific polysaccharide antibody deficiency (SAD) is poor and the criteria for defining a normal response lack consensus. We previously proposed fifth percentile (p5) values of PPV responses as a new cutoff for SAD. Objective To analyze the association of SAD (determined by either World Health Organization (WHO)-standardized ELISA or multiplex bead-based assay) with abnormal response to Salmonella (S.) typhi Vi vaccination in a cohort of patients with recurrent infections. Methods Ninety-four patients with a clinical history suggestive of antibody deficiency received PPV and S. typhi Vi vaccines. Polysaccharide responses to either 3 or 18 pneumococcal serotypes were measured by either the WHO ELISA or a multiplex in-house bead-based assay. Anti-S. typhi Vi IgG were measured by a commercial ELISA kit. Allohemagglutinins (AHA) were measured by agglutination method. Results Based on the American Academy of Allergy, Asthma and Immunology (AAAAI) criteria for WHO ELISA, 18/94 patients were diagnosed with SAD and 22/93 based on serotype-specific p5 cutoffs for bead-based assay. The association between the two methods was significant, with 10 subjects showing abnormal response according to both techniques. Abnormal response to S. typhi Vi vaccination was found in 7 patients, 6 of which had SAD. No correlation was found between polysaccharide response and AHA, age, or clinical phenotype. Conclusion The lack of evidence-based gold standards for the diagnosis of SAD represents a challenge in clinical practice. In our cohort, we confirmed the insufficient correlation between different methods of specific PPV response measurement, and showed that the S. typhi Vi response was not contributive. Caution in the interpretation of results is warranted until more reliable diagnostic methods can be validated.}},
  author       = {{Bucciol, Giorgia and Schaballie, Heidi and Schrijvers, Rik and Bosch, Barbara and Proesmans, Marijke and De Boeck, Kris and Boon, Mieke and Vermeulen, François and Lorent, Natalie and Dillaerts, Doreen and Kantsø, Bjørn and Jørgensen, Charlotte Svaerke and Emonds, Marie-Paule and Bossuyt, Xavier and Moens, Leen and Meyts, Isabelle}},
  issn         = {{0271-9142}},
  journal      = {{JOURNAL OF CLINICAL IMMUNOLOGY}},
  keywords     = {{Pneumococcal polysaccharide vaccine,specific antibody deficiency,polysaccharide antibody deficiency,primary immunodeficiency,antibody deficiency,Salmonella typhi,SAD,allohemagglutinins,ANTIPNEUMOCOCCAL POLYSACCHARIDE,PRIMARY IMMUNODEFICIENCY,CLINICAL INTERPRETATION,REFERENCE SERUM,DIAGNOSIS,VACCINATION,CHILDREN,IGG}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{105--113}},
  title        = {{Defining polysaccharide antibody deficiency : measurement of anti-pneumococcal antibodies and anti-Salmonella typhi antibodies in a cohort of patients with recurrent infections}},
  url          = {{http://doi.org/10.1007/s10875-019-00691-8}},
  volume       = {{40}},
  year         = {{2020}},
}

Altmetric

View in Altmetric

Web of Science

Times cited: